Tian Luo1, Xiaojuan Chen1, Danhe Wang1. 1. Department of Emergency, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China.
Abstract
OBJECTIVE: We aimed to investigate the clinical effect of predictive nursing combined with amiodarone on the treatment of tachyarrhythmia in patients with coronary heart disease (CHD). METHODS: The clinical data of 101 patients with CHD and tachyarrhythmia in our hospital were collected retrospectively and divided into two groups according to different intervention methods. Patients in group A (n=50) were treated with Propafenone, while patients in group B (n=51) were treated with Amiodarone. Meanwhile, patients in both groups were given predictive nursing. The therapeutic effect, cardiac function indexes, electrocardiogram (ECG) monitoring results, ventricular rate, chest pain recurrence, adverse reactions, the conversion rate of atrial fibrillation and re-infarction rate were compared between two groups before and after treatment. RESULTS: The total effective rate of group B was 94.21%, which was higher than 62.00% of group A (P<0.05). Compared with group A, group B had lower left ventricular end systolic diameter (LVESD) and left ventricular end diastolic diameter (LVEDD) and higher left ventricular ejection fraction (LVEF) after treatment (P<0.05). Group B also showed shorter QRS duration, longer PR interval and lower ventricular rate after treatment (P<0.05). The re-infarction rate and incidence of adverse reactions in group B was 3.92% and 5.88%, respectively, which was lower than 22.00% and 24.00% in group A, respectively (P<0.05). CONCLUSION: Predictive nursing combined with amiodarone has ideal clinical therapeutic effects on the treatment of tachyarrhythmia in patients with CHD. It can effectively improve cardiac function, increase the conversion rate of atrial fibrillation, and it can reduce re-infarction rate, recurrence rate of chest pain as well as incidence of adverse reactions. AJTR
OBJECTIVE: We aimed to investigate the clinical effect of predictive nursing combined with amiodarone on the treatment of tachyarrhythmia in patients with coronary heart disease (CHD). METHODS: The clinical data of 101 patients with CHD and tachyarrhythmia in our hospital were collected retrospectively and divided into two groups according to different intervention methods. Patients in group A (n=50) were treated with Propafenone, while patients in group B (n=51) were treated with Amiodarone. Meanwhile, patients in both groups were given predictive nursing. The therapeutic effect, cardiac function indexes, electrocardiogram (ECG) monitoring results, ventricular rate, chest pain recurrence, adverse reactions, the conversion rate of atrial fibrillation and re-infarction rate were compared between two groups before and after treatment. RESULTS: The total effective rate of group B was 94.21%, which was higher than 62.00% of group A (P<0.05). Compared with group A, group B had lower left ventricular end systolic diameter (LVESD) and left ventricular end diastolic diameter (LVEDD) and higher left ventricular ejection fraction (LVEF) after treatment (P<0.05). Group B also showed shorter QRS duration, longer PR interval and lower ventricular rate after treatment (P<0.05). The re-infarction rate and incidence of adverse reactions in group B was 3.92% and 5.88%, respectively, which was lower than 22.00% and 24.00% in group A, respectively (P<0.05). CONCLUSION: Predictive nursing combined with amiodarone has ideal clinical therapeutic effects on the treatment of tachyarrhythmia in patients with CHD. It can effectively improve cardiac function, increase the conversion rate of atrial fibrillation, and it can reduce re-infarction rate, recurrence rate of chest pain as well as incidence of adverse reactions. AJTR
Authors: Mohammed Ruzieh; Morgan K Moroi; Nader M Aboujamous; Mehrdad Ghahramani; Gerald V Naccarelli; John Mandrola; Andrew J Foy Journal: Am J Cardiol Date: 2019-09-26 Impact factor: 2.778
Authors: Peter J Kudenchuk; Siobhan P Brown; Mohamud Daya; Thomas Rea; Graham Nichol; Laurie J Morrison; Brian Leroux; Christian Vaillancourt; Lynn Wittwer; Clifton W Callaway; James Christenson; Debra Egan; Joseph P Ornato; Myron L Weisfeldt; Ian G Stiell; Ahamed H Idris; Tom P Aufderheide; James V Dunford; M Riccardo Colella; Gary M Vilke; Ashley M Brienza; Patrice Desvigne-Nickens; Pamela C Gray; Randal Gray; Norman Seals; Ron Straight; Paul Dorian Journal: N Engl J Med Date: 2016-04-04 Impact factor: 91.245
Authors: Mercedes Ortiz; Alfonso Martín; Fernando Arribas; Blanca Coll-Vinent; Carmen Del Arco; Rafael Peinado; Jesús Almendral Journal: Eur Heart J Date: 2017-05-01 Impact factor: 29.983